---
figid: PMC3508196__nihms-398021-f0001
figtitle: TARGETING ONCOGENIC BRAF IN HUMAN CANCER
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Danio rerio
- Diaporthe sclerotioides
- Antarctothoa delta
- Harvey murine sarcoma virus
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Danio rerio
- Drosophila melanogaster
pmcid: PMC3508196
filename: nihms-398021-f0001.jpg
figlink: /pmc/articles/PMC3508196/figure/F1/
number: F1
caption: The MAP kinase pathway is activated in human tumors by the binding of ligand
  to receptor tyrosine kinases (RTKs), by constitutive activation of an RTK, by loss
  of NF1 function, or by mutations in RAS, BRAF and MEK1. Phosphorylation and thus
  activation of ERK regulates transcription of target genes which promote cell cylce
  progression and tumor survival. The ERK pathway contains a classical feedback loop
  in which the expression of feedback elements such as SPRY and DUSP family proteins
  are regulated by ERK (dashed grey lines). Selected agents that target the MAP kinase
  and PI3 kinase/AKT pathway are shown (red).
papertitle: TARGETING ONCOGENIC BRAF IN HUMAN CANCER.
reftext: Christine Pratilas, et al. Curr Top Microbiol Immunol. ;355:83-98.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9418635
figid_alias: PMC3508196__F1
figtype: Figure
redirect_from: /figures/PMC3508196__F1
ndex: 319b3074-dea7-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3508196__nihms-398021-f0001.html
  '@type': Dataset
  description: The MAP kinase pathway is activated in human tumors by the binding
    of ligand to receptor tyrosine kinases (RTKs), by constitutive activation of an
    RTK, by loss of NF1 function, or by mutations in RAS, BRAF and MEK1. Phosphorylation
    and thus activation of ERK regulates transcription of target genes which promote
    cell cylce progression and tumor survival. The ERK pathway contains a classical
    feedback loop in which the expression of feedback elements such as SPRY and DUSP
    family proteins are regulated by ERK (dashed grey lines). Selected agents that
    target the MAP kinase and PI3 kinase/AKT pathway are shown (red).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Erbb2
  - Egfr
  - Kit
  - Nf1
  - ras
  - Hras
  - Kras
  - Rem1
  - Pik3r1
  - Pten
  - Zhx2
  - Akt1
  - Mdk
  - Mtor
  - Ephb2
  - Mapk1
  - Fos
  - Myc
  - Nol3
  - ERBB2
  - EGFR
  - KIT
  - NF1
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - SPRY1
  - SPRY2
  - SPRY3
  - SPRY4
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MTOR
  - DUSP5
  - DUSP1
  - DUSP2
  - DUSP3
  - DUSP4
  - DUSP6
  - EPHB2
  - MAPK1
  - MAPK3
  - ETS1
  - ETS2
  - FOS
  - FOSB
  - FOSL1
  - FOSL2
  - MYC
  - Pik3cg
  - Ephb1
  - erbb2
  - egfra
  - kita
  - nf1a
  - rab1ab
  - ptenb
  - mtor
  - fosab
  - myca
  - mycbp2
  - blo
  - Ras64B
  - Ras85D
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Raf
  - Akt
  - sty
  - Dsor1
  - Mtk
  - Tor
  - usp
  - Erk7
  - rl
  - Ets21C
  - Ets65A
  - pnt
  - Ets96B
  - Ets97D
  - Ets98B
  - kay
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
